Hologic (HOLX) Financials

$63.33 +1.16 (+1.87%)

As of 10:36 AM Eastern

Annual Income Statements for Hologic

This table shows Hologic's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	9/24/2022	9/25/2021	9/26/2020	9/28/2019	9/29/2018	9/30/2017	9/24/2016	9/26/2015
Net Income / (Loss) Attributable to Common Shareholders	790	456	1,302	1,872	1,115	-204	-111	-	331	132
Consolidated Net Income / (Loss)	790	456	1,302	1,870	1,111	-204	-111	756	331	132
Net Income / (Loss) Continuing Operations	790	456	1,302	1,870	1,111	-204	-111	-	331	132
Total Pre-Tax Income	865	676	1,588	2,361	1,002	-258	-419	1,231	415	177
Total Operating Income	883	668	1,640	2,480	1,105	-124	-238	1,370	549	455
Total Gross Profit	2,228	2,072	2,997	3,796	2,228	1,171	1,697	-	1,563	1,433
Total Revenue	4,030	4,030	4,863	5,632	3,776	3,367	3,218	-	2,833	2,705
Operating Revenue	4,030	4,030	4,863	5,632	3,776	3,367	3,218	3,059	2,833	2,705
Total Cost of Revenue	1,803	1,959	1,865	1,837	1,549	2,196	1,521	-	1,066	1,272
Operating Cost of Revenue	1,803	1,959	1,865	1,837	1,549	2,196	1,521	1,203	1,066	1,272
Total Operating Expenses	1,345	1,403	1,357	1,316	1,123	1,295	1,935	-	1,218	978
Selling, General & Admin Expense	409	392	408	433	356	332	366	343	267	261
Marketing Expense	585	595	630	561	485	565	545	499	415	363
Research & Development Expense	273	294	283	276	223	232	219	233	232	215
Amortization Expense	29	28	45	42	40	52	59	297	293	110
Other Operating Expenses / (Income)	1.70	-15	-40	-6.70	0.30	0.00	-	-	-	-
Impairment Charge	5.60	44	28	0.00	4.40	107	732	0.00	0.00	-
Restructuring Charge	41	12	2.40	9.30	15	6.60	14	13	11	29
Other Special Charges / (Income)	0.00	52	0.00	0.00	-	-	-	-900	0.00	0.00
Total Other Income / (Expense), net	-18	7.70	-52	-119	-103	-134	-181	-	-133	-278
Interest Expense	122	111	96	115	117	142	195	156	161	268
Interest & Investment Income	109	121	13	1.40	4.30	4.60	6.30	3.80	0.70	1.30
Other Income / (Expense), net	-4.10	-1.70	31	-5.40	9.10	3.10	7.60	13	27	-11
Income Tax Expense	76	220	286	491	-109	-54	-307	475	85	46
Basic Earnings per Share	$3.35	$1.85	$5.18	$7.28	$4.24	($0.76)	($0.40)	$2.70	$1.18	$0.47
Weighted Average Basic Shares Outstanding	235.72M	246.77M	251.53M	257.05M	262.73M	269.41M	275.11M	559.62M	280.21M	280.57M
Diluted Earnings per Share	$3.32	$1.83	$5.13	$7.21	$4.21	($0.76)	($0.40)	$2.64	$1.16	$0.45
Weighted Average Diluted Shares Outstanding	237.55M	248.83M	253.85M	259.71M	264.61M	269.41M	275.11M	565.46M	286.16M	289.54M
Weighted Average Basic & Diluted Shares Outstanding	226.94M	240.00M	245.83M	251.42M	257.01M	268.15M	289.21M	279.81M	280.30M	280M

This table shows Hologic's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Net Income / (Loss) Attributable to Common Shareholders	-17	201	179	195	170	247	91	-41	219	187	119
Consolidated Net Income / (Loss)	-17	201	179	195	170	247	91	-41	219	187	119
Net Income / (Loss) Continuing Operations	-17	201	179	195	170	247	91	-41	219	187	119
Total Pre-Tax Income	-29	248	222	241	212	191	146	12	279	239	144
Total Operating Income	-7.00	230	230	244	210	198	133	1.40	272	262	141
Total Gross Profit	377	581	558	560	542	568	500	368	586	618	515
Total Revenue	1,005	1,022	988	1,011	1,018	1,013	945	984	1,027	1,074	953
Operating Revenue	1,005	1,022	988	1,011	1,018	1,013	945	984	1,027	1,074	953
Total Cost of Revenue	628	441	430	451	476	446	445	617	441	456	439
Operating Cost of Revenue	628	441	430	451	476	446	445	617	441	456	439
Total Operating Expenses	384	351	328	316	332	369	368	366	314	356	374
Selling, General & Admin Expense	120	116	103	94	100	112	93	90	101	109	97
Marketing Expense	154	166	146	146	144	149	140	150	142	164	159
Research & Development Expense	62	60	67	64	75	67	73	73	74	75	76
Amortization Expense	3.80	4.70	4.90	5.30	5.70	13	6.30	7.10	7.10	7.60	12
Other Operating Expenses / (Income)	0.00	0.00	-	-	0.00	1.70	-	-	-12	0.00	-
Impairment Charge	38	0.00	-	0.40	0.90	4.30	-	44	0.00	0.00	-
Restructuring Charge	7.40	3.90	6.30	6.20	6.10	23	7.00	2.10	1.80	1.10	1.60
Total Other Income / (Expense), net	-22	18	-8.40	-3.30	1.10	-6.90	13	11	7.20	-23	2.60
Interest Expense	29	31	32	32	32	26	28	28	27	28	24
Interest & Investment Income	15	24	28	28	24	28	36	33	32	21	9.20
Other Income / (Expense), net	-7.30	24	-4.90	0.20	9.40	-8.80	5.30	5.90	2.90	-16	18
Income Tax Expense	-11	47	43	46	42	-55	55	53	61	52	25
Basic Earnings per Share	($0.08)	$0.87	$0.77	$0.83	$0.72	$1.03	$0.37	($0.16)	$0.88	$0.76	$0.49
Weighted Average Basic Shares Outstanding	225.77M	230.28M	235.72M	234.60M	235.89M	238.63M	246.77M	246.91M	247.73M	247.32M	251.53M
Diluted Earnings per Share	($0.08)	$0.87	$0.75	$0.82	$0.72	$1.03	$0.37	($0.16)	$0.87	$0.75	$0.48
Weighted Average Diluted Shares Outstanding	225.77M	232.11M	237.55M	236.47M	237.56M	240.21M	248.83M	246.91M	249.79M	249.28M	253.85M
Weighted Average Basic & Diluted Shares Outstanding	222.85M	224.39M	226.94M	232.27M	233.38M	234.73M	240.00M	244.94M	246.12M	246.55M	245.83M

This table details how cash moves in and out of Hologic's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	9/24/2022	9/25/2021	9/26/2020	9/28/2019	9/29/2018	9/30/2017	9/24/2016	9/26/2015
Net Change in Cash & Equivalents	-596	416	1,169	469	99	-65	133	-7.80	57	-245
Net Cash From Operating Activities	1,285	1,051	2,126	2,330	897	650	733	8.30	798	797
Net Cash From Continuing Operating Activities	1,285	1,051	2,126	2,330	897	650	733	8.30	798	797
Net Income / (Loss) Continuing Operations	790	456	1,302	1,870	1,111	-204	-111	756	331	132
Consolidated Net Income / (Loss)	790	456	1,302	1,870	1,111	-204	-111	756	331	132
Depreciation Expense	99	90	89	88	83	93	102	90	82	82
Amortization Expense	210	234	341	319	293	371	379	409	435	474
Non-Cash Adjustments To Reconcile Net Income	173	384	145	118	141	782	867	-785	49	160
Changes in Operating Assets and Liabilities, net	14	-112	249	-64	-730	-392	-504	-460	-99	-50
Net Cash From Investing Activities	-781	-152	-206	-1,330	-142	-281	-195	286	-68	-86
Net Cash From Continuing Investing Activities	-781	-152	-206	-1,330	-142	-281	-195	286	-68	-86
Purchase of Property, Plant & Equipment	-130	-150	-127	-178	-156	-109	-106	-108	-95	-89
Acquisitions	-307	-5.00	-159	-1,171	-119	-133	-77	-1,558	0.00	0.00
Purchase of Investments	-310	-10	0.00	-	-	-	-6.00	0.00	0.00	-
Divestitures	-31	0.00	0.00	-	139	0.00	0.00	1,865	0.00	0.00
Other Investing Activities, net	-2.00	13	80	19	-5.10	-38	-7.10	-0.60	-10	-6.70
Net Cash From Financing Activities	-1,109	-483	-756	-530	-660	-432	-405	-309	-671	-947
Net Cash From Continuing Financing Activities	-1,109	-483	-756	-530	-660	-432	-405	-309	-671	-947
Repayment of Debt	-288	-15	-1,700	-431	-796	-2,279	-4,176	-530	-693	-3,844
Repurchase of Common Equity	-835	-475	-542	-410	-654	-200	-276	-200	-250	0.00
Issuance of Common Equity	38	43	34	51	66	50	33	49	39	70
Other Financing Activities, net	-24	-36	-39	-52	-40	-23	-20	-22	-16	-26
Effect of Exchange Rate Changes	8.90	-	-	-1.70	4.10	-	-	7.30	-2.00	-8.10

This table details how cash moves in and out of Hologic's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Net Change in Cash & Equivalents	-353	-378	-279	259	248	-824	-9.30	183	141	102	-36
Net Cash From Operating Activities	169	189	367	406	292	220	259	333	206	253	169
Net Cash From Continuing Operating Activities	169	189	367	406	292	220	259	333	206	253	169
Net Income / (Loss) Continuing Operations	-17	201	179	195	170	247	91	-41	219	187	119
Consolidated Net Income / (Loss)	-17	201	179	195	170	247	91	-41	219	187	119
Depreciation Expense	24	23	24	23	23	30	23	22	22	23	22
Amortization Expense	52	51	51	50	51	59	53	59	59	63	85
Non-Cash Adjustments To Reconcile Net Income	270	11	27	38	48	61	69	242	24	50	47
Changes in Operating Assets and Liabilities, net	-159	-97	87	101	0.70	-175	24	50	-117	-70	-104
Net Cash From Investing Activities	-324	-22	-596	-43	-39	-104	-56	-39	-16	-41	-32
Net Cash From Continuing Investing Activities	-324	-22	-596	-43	-39	-104	-56	-39	-16	-41	-32
Purchase of Property, Plant & Equipment	-40	-32	-30	-34	-28	-38	-53	-37	-32	-29	-32
Acquisitions	-323	-16	-297	-	-	0.00	-5.00	-	-	-10	-
Purchase of Investments	-9.00	-6.00	-268	-3.00	-	-35	-	-	-	-	-
Sale and/or Maturity of Investments	48	32	-	-	-	0.00	-	-	-	-	-
Other Investing Activities, net	-0.60	-0.70	-0.40	4.30	-5.50	-0.40	1.50	-2.20	16	-1.90	-0.50
Net Cash From Financing Activities	-202	-537	-57	-104	-4.20	-944	-211	-110	-50	-114	-170
Net Cash From Continuing Financing Activities	-202	-537	-57	-104	-4.20	-944	-211	-110	-50	-114	-170
Repayment of Debt	-9.40	-9.40	-9.40	-9.30	-9.40	-259	-3.70	-3.80	-3.70	-3.80	-
Repurchase of Common Equity	-200	-517	-58	-100	-	-677	-211	-114	-50	-100	-175
Issuance of Common Equity	8.70	12	13	6.80	8.90	9.50	5.30	9.30	13	15	6.60
Other Financing Activities, net	-1.00	-23	-1.70	-1.30	-3.70	-17	-1.00	-1.50	-9.10	-25	-1.30

This table presents Hologic's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	9/24/2022	9/25/2021	9/26/2020	9/28/2019	9/29/2018	9/30/2017	9/24/2016	9/26/2015
Total Assets	9,156	9,139	9,071	8,920	7,196	6,442	7,231	7,980	7,317	7,643
Total Current Assets	3,823	4,185	3,862	3,169	2,222	1,793	1,723	1,479	1,327	1,266
Cash & Equivalents	2,160	2,723	0.00	0.00	701	602	667	541	548	491
Short-Term Investments	173	0.00	-	-	-	-	-	-	-	-
Accounts Receivable	600	626	618	943	1,029	649	579	534	447	416
Inventories, net	680	618	624	501	395	445	384	332	275	283
Prepaid Expenses	156	175	232	529	59	63	62	51	40	33
Current Deferred & Refundable Income Taxes	53	32	49	26	39	35	32	22	17	41
Plant, Property, & Equipment, net	538	517	482	565	492	471	478	473	460	457
Total Noncurrent Assets	4,795	4,438	4,728	5,187	4,482	4,178	5,030	6,028	5,530	5,920
Long-Term Investments	96	0.00	-	-	-	-	-	-	-	-
Goodwill	3,443	3,281	3,237	3,282	2,658	2,564	2,533	3,171	2,803	2,808
Intangible Assets	845	889	1,281	1,659	1,308	1,460	2,399	2,772	2,643	3,023
Other Noncurrent Operating Assets	411	268	211	246	517	155	98	85	84	88
Total Liabilities & Shareholders' Equity	9,156	9,139	9,071	8,920	7,196	6,442	7,231	7,980	7,317	7,643
Total Liabilities	4,026	4,122	4,195	4,701	4,489	4,326	4,802	5,195	5,174	5,563
Total Current Liabilities	1,037	1,207	938	1,327	1,239	1,070	1,403	1,866	902	943
Short-Term Debt	38	287	15	313	325	273	601	1,152	296	391
Accounts Payable	204	175	198	216	179	187	192	167	157	117
Accrued Expenses	580	535	535	596	548	431	436	375	288	272
Current Deferred Revenue	213	199	187	198	186	180	173	171	161	163
Other Current Liabilities	3.30	3.10	3.20	3.70	1.90	-	-	-	-	-
Total Noncurrent Liabilities	2,989	2,915	3,257	3,375	3,249	3,256	3,400	3,329	4,272	4,620
Long-Term Debt	2,497	2,531	2,808	2,712	2,714	2,784	2,705	2,172	3,049	3,221
Capital Lease Obligations	12	15	18	23	-	19	21	23	0.00	-
Noncurrent Deferred Revenue	14	14	9.40	20	13	16	18	21	16	20
Noncurrent Deferred & Payable Income Tax Liabilities	59	20	91	251	202	275	498	974	983	1,178
Other Noncurrent Operating Liabilities	406	335	331	369	321	162	158	140	225	201
Total Equity & Noncontrolling Interests	5,130	5,017	4,876	4,219	2,707	2,116	2,429	2,785	2,143	2,079
Total Preferred & Common Equity	5,130	5,017	4,876	4,219	2,705	2,116	2,429	2,785	2,143	2,079
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,130	5,017	4,876	4,219	2,705	2,116	2,429	2,785	2,143	2,079
Common Stock	6,247	6,144	6,046	5,969	5,908	5,773	5,674	5,634	5,563	5,563
Retained Earnings	2,846	2,056	1,600	298	-1,573	-2,689	-2,494	-2,383	-3,138	-3,469
Treasury Stock	-3,852	-3,036	-2,532	-1,989	-1,580	-926	-726	-450	-250	0.00
Accumulated Other Comprehensive Income / (Loss)	-112	-148	-238	-59	-50	-42	-26	-16	-32	-15

This table presents Hologic's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Total Assets	8,545	8,729	9,156	8,890	8,714	8,470	9,139	9,338	9,449	9,290	9,071
Total Current Assets	3,209	3,494	3,823	3,997	3,789	3,494	4,185	4,339	4,211	4,021	3,862
Cash & Equivalents	1,430	1,782	2,160	2,439	2,180	1,932	2,723	2,765	2,582	2,441	0.00
Short-Term Investments	192	191	173	-	-	-	0.00	-	-	-	-
Accounts Receivable	644	631	600	629	647	671	626	687	714	674	618
Inventories, net	717	707	680	666	649	634	618	680	688	678	624
Prepaid Expenses	166	158	156	158	312	258	175	207	228	228	232
Current Deferred & Refundable Income Taxes	61	24	53	106	-	-	32	-	-	-	49
Plant, Property, & Equipment, net	556	537	538	529	525	527	517	493	498	494	482
Total Noncurrent Assets	4,781	4,698	4,795	4,364	4,401	4,448	4,438	4,505	4,739	4,775	4,728
Long-Term Investments	0.00	48	96	-	-	-	0.00	-	-	-	-
Goodwill	3,624	3,423	3,443	3,291	3,292	3,306	3,281	3,298	3,297	3,290	3,237
Intangible Assets	674	793	845	688	752	833	889	940	1,202	1,255	1,281
Other Noncurrent Operating Assets	483	434	411	386	357	310	268	267	240	230	211
Total Liabilities & Shareholders' Equity	8,545	8,729	9,156	8,890	8,714	8,470	9,139	9,338	9,449	9,290	9,071
Total Liabilities	3,926	3,955	4,026	3,939	3,870	3,816	4,122	4,156	4,148	4,198	4,195
Total Current Liabilities	990	1,002	1,037	1,002	955	899	1,207	981	955	956	938
Short-Term Debt	56	47	38	38	37	37	287	32	26	21	15
Accounts Payable	209	237	204	202	203	184	175	181	187	202	198
Accrued Expenses	508	528	580	541	504	484	535	533	508	539	535
Current Deferred Revenue	213	188	213	219	208	191	199	233	231	192	187
Other Current Liabilities	3.30	3.30	3.30	3.20	3.20	3.20	3.10	2.90	2.90	3.20	3.20
Total Noncurrent Liabilities	2,937	2,953	2,989	2,937	2,915	2,917	2,915	3,175	3,193	3,242	3,257
Long-Term Debt	2,461	2,479	2,497	2,506	2,514	2,523	2,531	2,789	2,798	2,806	2,808
Capital Lease Obligations	10	11	12	13	14	15	15	16	17	18	18
Noncurrent Deferred Revenue	12	12	14	15	15	14	14	14	13	11	9.40
Noncurrent Deferred & Payable Income Tax Liabilities	47	54	59	18	18	20	20	19	33	72	91
Other Noncurrent Operating Liabilities	406	397	406	386	354	345	335	336	332	335	331
Total Equity & Noncontrolling Interests	4,619	4,773	5,130	4,951	4,844	4,654	5,017	5,182	5,301	5,093	4,876
Total Preferred & Common Equity	4,619	4,773	5,130	4,951	4,844	4,654	5,017	5,182	5,301	5,093	4,876
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,619	4,773	5,130	4,951	4,844	4,654	5,017	5,182	5,301	5,093	4,876
Common Stock	6,305	6,262	6,247	6,216	6,201	6,062	6,144	6,126	6,095	6,064	6,046
Retained Earnings	3,029	3,047	2,846	2,667	2,473	2,303	2,056	1,966	2,006	1,788	1,600
Treasury Stock	-4,575	-4,373	-3,852	-3,793	-3,692	-3,592	-3,036	-2,796	-2,682	-2,632	-2,532
Accumulated Other Comprehensive Income / (Loss)	-140	-163	-112	-140	-137	-119	-148	-114	-118	-127	-238

This table displays calculated financial ratios and metrics derived from Hologic's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	9/28/2024	9/30/2023	9/24/2022	9/25/2021	9/26/2020	9/28/2019	9/29/2018	9/30/2017	9/24/2016	9/26/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-17.12%	-13.66%	49.14%	12.15%	4.64%	0.00%	7.98%	4.72%	6.89%
EBITDA Growth	19.94%	-52.88%	-27.09%	93.40%	335.19%	36.96%	-86.71%	72.21%	9.35%	15.30%
EBIT Growth	31.77%	-60.10%	-32.48%	122.14%	1,023.03%	47.59%	-116.65%	140.46%	29.52%	61.61%
NOPAT Growth	78.67%	-66.47%	-31.54%	60.36%	1,513.31%	47.96%	-119.80%	92.52%	29.29%	235.97%
Net Income Growth	73.14%	-64.98%	-30.36%	68.37%	645.43%	-82.93%	-114.73%	128.39%	151.37%	660.69%
EPS Growth	81.42%	-64.33%	-28.85%	71.26%	653.95%	-90.00%	-115.15%	127.59%	157.78%	650.00%
Operating Cash Flow Growth	22.26%	-50.55%	-8.78%	159.92%	38.04%	-11.38%	8,730.12%	-98.96%	0.18%	56.73%
Free Cash Flow Firm Growth	0.28%	-66.41%	125.97%	18.62%	86.59%	22.83%	77.03%	-72.75%	-4.45%	70.78%
Invested Capital Growth	2.16%	-4.50%	-11.78%	20.84%	9.92%	-9.81%	-8.98%	13.19%	-4.98%	-6.99%
Revenue Q/Q Growth	1.07%	-0.20%	-6.95%	-0.54%	14.60%	1.58%	0.00%	2.55%	0.85%	1.58%
EBITDA Q/Q Growth	7.85%	-4.96%	-11.97%	-6.04%	91.46%	-35.13%	-10.68%	-1.80%	2.17%	1.25%
EBIT Q/Q Growth	11.03%	-3.00%	-14.11%	-7.78%	190.74%	-267.41%	-2.17%	-2.65%	5.87%	5.61%
NOPAT Q/Q Growth	15.41%	-7.26%	-14.90%	-7.29%	68.61%	-300.65%	-4.53%	-1.12%	4.68%	13.51%
Net Income Q/Q Growth	12.54%	-5.80%	-13.89%	-8.10%	125.03%	-587.84%	-40.71%	-1.24%	25.40%	-2.16%
EPS Q/Q Growth	12.93%	-5.67%	-13.64%	-7.68%	126.34%	-660.00%	-29.03%	-1.49%	27.47%	-4.26%
Operating Cash Flow Q/Q Growth	9.20%	9.37%	-12.25%	1.01%	27.67%	2.41%	9.86%	-88.18%	-1.81%	16.27%
Free Cash Flow Firm Q/Q Growth	-21.45%	-0.37%	-10.59%	20.34%	1.38%	27.34%	53.12%	-46.01%	1.66%	8.62%
Invested Capital Q/Q Growth	3.53%	-2.25%	-1.56%	-1.53%	4.43%	-5.63%	-1.08%	1.24%	-1.67%	-1.74%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.28%	51.40%	61.64%	67.39%	58.98%	34.77%	52.73%	52.99%	55.19%	52.96%
EBITDA Margin	29.46%	24.57%	43.21%	51.17%	39.46%	10.17%	7.77%	61.52%	38.57%	36.94%
Operating Margin	21.90%	16.58%	33.73%	44.04%	29.26%	-3.68%	-7.39%	44.80%	19.37%	16.82%
EBIT Margin	21.80%	16.54%	34.37%	43.94%	29.50%	-3.58%	-7.16%	45.22%	20.31%	16.42%
Profit (Net Income) Margin	19.59%	11.31%	26.77%	33.20%	29.41%	-6.05%	-3.46%	24.70%	11.68%	4.87%
Tax Burden Percent	91.26%	67.45%	81.98%	79.19%	110.84%	79.01%	26.59%	61.40%	79.65%	74.27%
Interest Burden Percent	98.47%	101.41%	95.04%	95.40%	89.93%	213.50%	181.76%	88.97%	72.20%	39.90%
Effective Tax Rate	8.74%	32.55%	18.02%	20.81%	-10.84%	0.00%	0.00%	38.60%	20.35%	25.73%
Return on Invested Capital (ROIC)	15.52%	8.58%	23.44%	35.26%	25.42%	-1.79%	-3.12%	15.98%	8.62%	6.27%
ROIC Less NNEP Spread (ROIC-NNEP)	1.98%	10.25%	19.85%	30.78%	20.67%	-6.35%	-1.10%	12.92%	5.03%	0.05%
Return on Net Nonoperating Assets (RNNOA)	0.05%	0.64%	5.19%	18.73%	20.63%	-7.17%	-1.15%	14.69%	7.05%	0.09%
Return on Equity (ROE)	15.56%	9.22%	28.63%	53.99%	46.05%	-8.96%	-4.27%	30.67%	15.67%	6.35%
Cash Return on Invested Capital (CROIC)	13.38%	13.18%	35.96%	16.39%	15.97%	8.52%	6.29%	3.60%	13.73%	13.50%
Operating Return on Assets (OROA)	9.60%	7.32%	18.58%	30.71%	16.34%	-1.77%	-3.03%	18.08%	7.69%	5.53%
Return on Assets (ROA)	8.63%	5.01%	14.47%	23.20%	16.29%	-2.98%	-1.46%	9.88%	4.42%	1.64%
Return on Common Equity (ROCE)	15.56%	9.22%	28.63%	53.98%	46.03%	-8.96%	-4.27%	30.67%	15.67%	6.35%
Return on Equity Simple (ROE_SIMPLE)	15.39%	9.09%	26.70%	44.32%	41.05%	-9.62%	-4.58%	27.13%	15.44%	6.33%
Net Operating Profit after Tax (NOPAT)	805	451	1,345	1,964	1,225	-87	-167	841	437	338
NOPAT Margin	19.99%	11.19%	27.65%	34.87%	32.43%	-2.57%	-5.18%	27.50%	15.43%	12.49%
Net Nonoperating Expense Percent (NNEP)	13.53%	-1.67%	3.58%	4.48%	4.75%	4.56%	-2.02%	3.06%	3.59%	6.21%
Cost of Revenue to Revenue	44.72%	48.60%	38.36%	32.61%	41.02%	65.23%	47.27%	47.01%	37.62%	47.04%
SG&A Expenses to Revenue	10.16%	9.74%	8.38%	7.69%	9.42%	9.87%	11.38%	11.22%	9.44%	9.65%
R&D to Revenue	6.77%	7.30%	5.83%	4.91%	5.89%	6.90%	6.80%	7.61%	8.19%	7.94%
Operating Expenses to Revenue	33.38%	34.81%	27.91%	23.36%	29.72%	38.45%	60.12%	8.20%	43.01%	36.14%
Earnings before Interest and Taxes (EBIT)	879	667	1,671	2,475	1,114	-121	-230	1,383	575	444
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,188	990	2,101	2,882	1,490	342	250	1,882	1,093	999
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.66	3.39	3.22	4.60	6.16	6.27	4.59	3.76	4.98	5.42
Price to Tangible Book Value (P/TBV)	22.29	20.07	43.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.66	4.22	3.23	3.44	4.41	3.94	3.47	3.43	3.77	4.17
Price to Earnings (P/E)	23.78	37.28	12.08	10.36	14.94	0.00	0.00	13.87	32.25	85.65
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.21%	2.68%	8.28%	9.65%	6.69%	0.00%	0.00%	7.21%	3.10%	1.17%
Enterprise Value to Invested Capital (EV/IC)	3.60	3.33	3.45	3.68	3.77	3.43	2.71	2.38	2.73	2.77
Enterprise Value to Revenue (EV/Rev)	4.69	4.25	3.82	3.98	5.03	4.67	4.29	4.34	4.75	5.32
Enterprise Value to EBITDA (EV/EBITDA)	15.91	17.28	8.84	7.79	12.75	45.96	55.25	7.06	12.32	14.40
Enterprise Value to EBIT (EV/EBIT)	21.50	25.66	11.11	9.06	17.06	0.00	0.00	9.61	23.41	32.41
Enterprise Value to NOPAT (EV/NOPAT)	23.45	37.95	13.81	11.42	15.52	0.00	0.00	15.79	30.81	42.58
Enterprise Value to Operating Cash Flow (EV/OCF)	14.70	16.28	8.73	9.63	21.20	24.23	18.85	1,600.87	16.87	18.06
Enterprise Value to Free Cash Flow (EV/FCFF)	27.19	24.70	9.00	24.58	24.70	38.15	41.13	70.05	19.35	19.76
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.50	0.56	0.58	0.72	1.12	1.45	1.37	1.20	1.56	1.74
Long-Term Debt to Equity	0.49	0.51	0.58	0.65	1.00	1.32	1.12	0.79	1.42	1.55
Financial Leverage	0.02	0.06	0.26	0.61	1.00	1.13	1.05	1.14	1.40	1.60
Leverage Ratio	1.80	1.84	1.98	2.33	2.83	3.01	2.92	3.10	3.54	3.88
Compound Leverage Factor	1.78	1.87	1.88	2.22	2.54	6.42	5.30	2.76	2.56	1.55
Debt to Total Capital	33.18%	36.09%	36.82%	41.95%	52.88%	59.25%	57.80%	54.59%	60.96%	63.47%
Short-Term Debt to Total Capital	0.49%	3.66%	0.19%	4.31%	5.65%	5.26%	10.45%	18.79%	5.39%	6.87%
Long-Term Debt to Total Capital	32.69%	32.44%	36.62%	37.64%	47.23%	53.99%	47.35%	35.79%	55.56%	56.59%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	66.82%	63.91%	63.18%	58.05%	47.08%	40.75%	42.20%	45.41%	39.04%	36.53%
Debt to EBITDA	2.14	2.86	1.35	1.06	2.04	8.98	13.31	1.78	3.06	3.61
Net Debt to EBITDA	0.10	0.11	1.35	1.06	1.57	7.23	10.64	1.49	2.56	3.12
Long-Term Debt to EBITDA	2.11	2.57	1.35	0.95	1.82	8.19	10.90	1.17	2.79	3.22
Debt to NOPAT	3.16	6.29	2.11	1.55	2.48	-35.50	-19.98	3.98	7.66	10.69
Net Debt to NOPAT	0.15	0.25	2.11	1.55	1.91	-28.55	-15.97	3.34	6.40	9.23
Long-Term Debt to NOPAT	3.12	5.65	2.10	1.39	2.22	-32.34	-16.37	2.61	6.98	9.53
Altman Z-Score	4.35	3.86	4.03	4.32	3.12	1.85	1.30	1.69	1.35	1.18
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.03%	0.04%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.69	3.47	4.12	2.39	1.79	1.68	1.23	0.79	1.47	1.34
Quick Ratio	2.83	2.77	0.66	0.71	1.40	1.17	0.89	0.58	1.10	0.96
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	695	693	2,063	913	770	412	336	190	696	728
Operating Cash Flow to CapEx	987.10%	699.87%	1,671.15%	1,311.42%	573.27%	595.33%	694.03%	7.71%	844.66%	891.28%
Free Cash Flow to Firm to Interest Expense	5.69	6.24	21.53	7.92	6.61	2.91	1.73	1.21	4.33	2.72
Operating Cash Flow to Interest Expense	10.53	9.46	22.19	20.23	7.70	4.59	3.77	0.05	4.97	2.97
Operating Cash Flow Less CapEx to Interest Expense	9.46	8.11	20.86	18.69	6.35	3.82	3.22	-0.63	4.38	2.64
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.44	0.44	0.54	0.70	0.55	0.49	0.42	0.40	0.38	0.34
Accounts Receivable Turnover	6.57	6.48	6.23	5.71	4.50	5.48	5.78	6.24	6.56	6.66
Inventory Turnover	2.78	3.16	3.32	4.10	3.69	5.30	4.25	4.74	3.82	4.15
Fixed Asset Turnover	7.64	8.07	9.30	10.67	7.85	7.10	6.77	6.56	6.18	5.89
Accounts Payable Turnover	9.51	10.51	9.02	9.31	8.48	11.60	8.48	8.89	7.78	12.17
Days Sales Outstanding (DSO)	55.52	56.29	58.56	63.88	81.07	66.55	63.11	58.50	55.61	54.79
Days Inventory Outstanding (DIO)	131.36	115.65	110.05	89.07	98.97	68.88	85.86	76.96	95.52	88.03
Days Payable Outstanding (DPO)	38.37	34.74	40.46	39.22	43.04	31.47	43.05	41.06	46.91	29.99
Cash Conversion Cycle (CCC)	148.50	137.20	128.15	113.73	137.00	103.97	105.92	94.40	104.22	112.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,247	5,136	5,378	6,096	5,045	4,590	5,089	5,591	4,940	5,199
Invested Capital Turnover	0.78	0.77	0.85	1.01	0.78	0.70	0.60	0.58	0.56	0.50
Increase / (Decrease) in Invested Capital	111	-242	-718	1,051	455	-499	-502	652	-259	-390
Enterprise Value (EV)	18,889	17,110	18,565	22,435	19,006	15,735	13,812	13,287	13,464	14,392
Market Capitalization	18,772	16,999	15,723	19,387	16,666	13,261	11,152	10,481	10,667	11,272
Book Value per Share	$22.09	$20.48	$19.53	$16.64	$10.45	$7.91	$8.93	$9.75	$7.72	$7.38
Tangible Book Value per Share	$3.63	$3.46	$1.44	($2.85)	($4.87)	($7.14)	($9.20)	($11.06)	($11.91)	($13.32)
Total Capital	7,677	7,850	7,718	7,267	5,746	5,192	5,756	6,132	5,488	5,691
Total Debt	2,547	2,834	2,841	3,048	3,039	3,076	3,327	3,347	3,345	3,612
Total Long-Term Debt	2,509	2,547	2,826	2,735	2,714	2,803	2,726	2,195	3,049	3,221
Net Debt	117	111	2,841	3,048	2,338	2,474	2,660	2,807	2,797	3,120
Capital Expenditures (CapEx)	130	150	127	178	156	109	106	108	95	89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	490	542	2,939	2,155	607	394	255	225	172	221
Debt-free Net Working Capital (DFNWC)	2,824	3,264	2,939	2,155	1,308	996	922	766	721	714
Net Working Capital (NWC)	2,786	2,977	2,924	1,842	983	723	321	-387	425	322
Net Nonoperating Expense (NNE)	16	-5.19	43	94	114	117	-55	86	106	206
Net Nonoperating Obligations (NNO)	117	119	502	1,878	2,338	2,474	2,660	2,807	2,797	3,120
Total Depreciation and Amortization (D&A)	309	323	430	407	376	463	480	499	518	555
Debt-free, Cash-free Net Working Capital to Revenue	12.16%	13.44%	60.44%	38.26%	16.07%	11.71%	7.93%	7.35%	6.08%	8.17%
Debt-free Net Working Capital to Revenue	70.06%	80.99%	60.44%	38.26%	34.63%	29.58%	28.65%	25.03%	25.44%	26.38%
Net Working Capital to Revenue	69.13%	73.87%	60.14%	32.70%	26.03%	21.47%	9.96%	-12.65%	14.99%	11.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.35	$1.85	$5.18	$7.28	$4.24	($0.76)	($0.40)	$2.70	$1.18	$0.47
Adjusted Weighted Average Basic Shares Outstanding	235.72M	246.77M	251.53M	257.05M	262.73M	269.41M	275.11M	279.81M	280.21M	280.57M
Adjusted Diluted Earnings per Share	$3.32	$1.83	$5.13	$7.21	$4.21	($0.76)	($0.40)	$2.64	$1.16	$0.45
Adjusted Weighted Average Diluted Shares Outstanding	237.55M	248.83M	253.85M	259.71M	264.61M	269.41M	275.11M	285.65M	286.16M	289.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	226.94M	240.00M	245.83M	251.42M	257.01M	268.15M	289.21M	0.00	278.22M	282.91M
Normalized Net Operating Profit after Tax (NOPAT)	848	524	1,369	1,971	787	-7.35	356	297	445	359
Normalized NOPAT Margin	21.04%	12.99%	28.16%	35.00%	20.85%	-0.22%	11.05%	9.71%	15.72%	13.28%
Pre Tax Income Margin	21.46%	16.78%	32.66%	41.92%	26.53%	-7.65%	-13.01%	40.23%	14.66%	6.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.19	6.00	17.44	21.48	9.56	-0.85	-1.18	8.84	3.58	1.66
NOPAT to Interest Expense	6.60	4.06	14.04	17.05	10.51	-0.61	-0.86	5.38	2.72	1.26
EBIT Less CapEx to Interest Expense	6.13	4.65	16.12	19.94	8.22	-1.62	-1.73	8.16	2.99	1.32
NOPAT Less CapEx to Interest Expense	5.53	2.71	12.71	15.51	9.17	-1.38	-1.40	4.69	2.13	0.93
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.45%	0.16%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	105.78%	104.12%	41.64%	22.37%	59.02%	-98.28%	-247.80%	26.49%	75.57%	0.00%

This table displays calculated financial ratios and metrics derived from Hologic's official financial filings.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.23%	0.86%	4.52%	2.74%	-0.85%	-5.69%	-0.84%	-1.83%	-28.50%	-26.98%	-27.59%
EBITDA Growth	-78.91%	18.00%	40.51%	257.63%	-17.51%	-16.45%	-19.51%	-76.59%	-49.34%	-56.01%	-51.89%
EBIT Growth	-106.51%	34.00%	63.35%	3,245.21%	-20.07%	-23.20%	-13.01%	-97.28%	-53.87%	-61.93%	-63.42%
NOPAT Growth	-102.90%	-26.93%	124.83%	4,307.61%	-20.60%	24.18%	-29.26%	-101.93%	-54.84%	-60.05%	-66.87%
Net Income Growth	-110.24%	-18.46%	97.13%	580.25%	-22.24%	31.54%	-23.67%	-117.73%	-52.05%	-62.46%	-63.90%
EPS Growth	-111.11%	-15.53%	102.70%	612.50%	-17.24%	37.33%	-22.92%	-117.78%	-51.67%	-61.54%	-62.79%
Operating Cash Flow Growth	-42.07%	-13.95%	41.86%	21.94%	41.74%	-13.18%	53.44%	0.64%	-80.58%	-55.09%	-63.77%
Free Cash Flow Firm Growth	-160.26%	-57.47%	-76.99%	87.51%	103.71%	-49.37%	-61.13%	-78.90%	-61.26%	283.38%	219.35%
Invested Capital Growth	5.65%	-0.13%	2.16%	-3.55%	-5.93%	-3.62%	-4.50%	-3.83%	-0.57%	-11.19%	-11.78%
Revenue Q/Q Growth	-1.61%	3.42%	-2.31%	-0.63%	0.46%	7.17%	-3.97%	-4.10%	-4.44%	12.68%	-4.93%
EBITDA Q/Q Growth	-81.12%	9.38%	-5.31%	7.84%	5.65%	30.24%	141.02%	-75.13%	7.01%	25.47%	-29.91%
EBIT Q/Q Growth	-105.63%	12.75%	-7.82%	11.10%	16.05%	37.45%	1,787.67%	-97.35%	11.52%	55.68%	-41.05%
NOPAT Q/Q Growth	-102.63%	0.68%	-5.98%	16.66%	-33.82%	209.76%	1,859.48%	-102.20%	3.50%	76.46%	-51.97%
Net Income Q/Q Growth	-108.66%	12.54%	-8.17%	14.48%	-31.08%	172.08%	323.70%	-118.54%	16.60%	57.88%	-48.03%
EPS Q/Q Growth	-109.20%	16.00%	-8.54%	13.89%	-30.10%	178.38%	331.25%	-118.39%	16.00%	56.25%	-46.67%
Operating Cash Flow Q/Q Growth	-10.51%	-48.42%	-9.56%	38.78%	32.91%	-14.96%	-22.27%	61.32%	-18.59%	50.30%	-49.02%
Free Cash Flow Firm Q/Q Growth	-255.49%	158.91%	-80.54%	-23.08%	9.73%	40.11%	58.57%	-16.44%	-72.73%	7.56%	-13.93%
Invested Capital Q/Q Growth	4.45%	0.82%	3.53%	-3.10%	-1.26%	3.12%	-2.25%	-5.49%	1.16%	2.19%	-1.56%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.53%	56.81%	56.45%	55.40%	53.28%	56.02%	52.93%	37.33%	57.07%	57.52%	53.99%
EBITDA Margin	6.16%	32.08%	30.33%	31.29%	28.84%	27.42%	22.56%	8.99%	34.66%	30.95%	27.80%
Operating Margin	-0.70%	22.49%	23.28%	24.13%	20.67%	19.56%	14.02%	0.14%	26.51%	24.43%	14.78%
EBIT Margin	-1.42%	24.84%	22.78%	24.14%	21.60%	18.70%	14.58%	0.74%	26.79%	22.96%	16.62%
Profit (Net Income) Margin	-1.73%	19.67%	18.08%	19.23%	16.69%	24.33%	9.58%	-4.11%	21.29%	17.45%	12.45%
Tax Burden Percent	61.05%	81.21%	80.60%	80.81%	80.33%	128.86%	62.23%	-334.71%	78.23%	78.38%	82.72%
Interest Burden Percent	199.30%	97.52%	98.45%	98.57%	96.22%	101.00%	105.66%	165.75%	101.56%	96.96%	90.59%
Effective Tax Rate	0.00%	18.79%	19.40%	19.19%	19.67%	-28.86%	37.77%	434.71%	21.77%	21.62%	17.28%
Return on Invested Capital (ROIC)	-0.37%	13.94%	14.57%	15.06%	12.19%	18.54%	6.69%	-0.36%	15.09%	14.64%	10.36%
ROIC Less NNEP Spread (ROIC-NNEP)	-2.30%	16.42%	8.83%	12.24%	12.47%	16.84%	9.31%	-13.67%	16.15%	12.87%	10.54%
Return on Net Nonoperating Assets (RNNOA)	-0.31%	2.02%	0.21%	0.23%	0.79%	1.81%	0.58%	-0.72%	1.69%	2.78%	2.76%
Return on Equity (ROE)	-0.68%	15.96%	14.77%	15.29%	12.98%	20.35%	7.27%	-1.08%	16.78%	17.41%	13.12%
Cash Return on Invested Capital (CROIC)	5.09%	14.07%	13.38%	17.14%	14.48%	12.87%	13.18%	12.98%	14.51%	29.59%	35.96%
Operating Return on Assets (OROA)	-0.66%	11.67%	10.04%	10.56%	9.42%	8.36%	6.45%	0.32%	11.46%	11.04%	8.98%
Return on Assets (ROA)	-0.81%	9.24%	7.96%	8.41%	7.28%	10.88%	4.24%	-1.78%	9.11%	8.39%	6.73%
Return on Common Equity (ROCE)	-0.68%	15.96%	14.77%	15.29%	12.98%	20.35%	7.27%	-1.08%	16.78%	17.41%	13.12%
Return on Equity Simple (ROE_SIMPLE)	12.05%	15.59%	0.00%	14.17%	9.63%	11.07%	0.00%	9.34%	14.21%	19.44%	0.00%
Net Operating Profit after Tax (NOPAT)	-4.90	187	185	197	169	255	82	-4.69	213	206	117
NOPAT Margin	-0.49%	18.26%	18.76%	19.49%	16.61%	25.21%	8.72%	-0.48%	20.74%	19.15%	12.23%
Net Nonoperating Expense Percent (NNEP)	1.94%	-2.48%	5.74%	2.82%	-0.27%	1.70%	-2.62%	13.31%	-1.07%	1.76%	-0.18%
Return On Investment Capital (ROIC_SIMPLE)	-0.07%	2.55%	-	-	-	3.53%	-	-	-	-	-
Cost of Revenue to Revenue	62.47%	43.19%	43.55%	44.60%	46.72%	43.98%	47.08%	62.67%	42.93%	42.48%	46.01%
SG&A Expenses to Revenue	11.91%	11.32%	10.45%	9.29%	9.86%	11.04%	9.83%	9.16%	9.82%	10.10%	10.22%
R&D to Revenue	6.12%	5.90%	6.81%	6.34%	7.33%	6.59%	7.71%	7.38%	7.21%	6.96%	7.97%
Operating Expenses to Revenue	38.23%	34.32%	33.17%	31.27%	32.61%	36.45%	38.91%	37.19%	30.56%	33.09%	39.21%
Earnings before Interest and Taxes (EBIT)	-14	254	225	244	220	189	138	7.30	275	247	158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	62	328	300	317	294	278	213	89	356	333	265
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.98	3.45	3.66	3.50	3.78	3.76	3.39	3.85	3.75	3.61	3.22
Price to Tangible Book Value (P/TBV)	42.88	29.57	22.29	17.82	22.87	33.97	20.07	21.12	24.82	33.59	43.78
Price to Revenue (P/Rev)	3.42	4.08	4.66	4.35	4.62	4.41	4.22	4.93	4.90	4.12	3.23
Price to Earnings (P/E)	24.72	22.15	23.78	24.70	39.23	33.98	37.28	41.17	26.42	18.57	12.08
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.05%	4.52%	4.21%	4.05%	2.55%	2.94%	2.68%	2.43%	3.78%	5.38%	8.28%
Enterprise Value to Invested Capital (EV/IC)	2.65	3.21	3.60	3.44	3.57	3.43	3.33	3.81	3.63	3.42	3.45
Enterprise Value to Revenue (EV/Rev)	3.64	4.21	4.69	4.37	4.72	4.57	4.25	4.95	4.97	4.21	3.82
Enterprise Value to EBITDA (EV/EBITDA)	14.58	13.73	15.91	15.84	21.40	19.40	17.28	19.20	15.14	11.20	8.84
Enterprise Value to EBIT (EV/EBIT)	20.69	18.02	21.50	22.05	33.71	29.77	25.66	29.10	21.25	14.80	11.11
Enterprise Value to NOPAT (EV/NOPAT)	25.76	23.02	23.45	25.00	41.38	36.63	37.95	41.14	25.94	18.14	13.81
Enterprise Value to Operating Cash Flow (EV/OCF)	12.96	13.55	14.70	14.82	16.93	17.83	16.28	20.81	21.02	10.36	8.73
Enterprise Value to Free Cash Flow (EV/FCFF)	53.59	22.81	27.19	19.72	23.91	26.12	24.70	28.76	24.91	10.87	9.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.55	0.53	0.50	0.52	0.53	0.55	0.56	0.55	0.54	0.56	0.58
Long-Term Debt to Equity	0.54	0.52	0.49	0.51	0.52	0.55	0.51	0.54	0.53	0.55	0.58
Financial Leverage	0.14	0.12	0.02	0.02	0.06	0.11	0.06	0.05	0.10	0.22	0.26
Leverage Ratio	1.82	1.82	1.80	1.80	1.79	1.82	1.84	1.84	1.88	1.93	1.98
Compound Leverage Factor	3.64	1.78	1.78	1.77	1.72	1.84	1.94	3.04	1.91	1.87	1.79
Debt to Total Capital	35.37%	34.71%	33.18%	34.05%	34.62%	35.62%	36.09%	35.38%	34.89%	35.84%	36.82%
Short-Term Debt to Total Capital	0.79%	0.64%	0.49%	0.50%	0.50%	0.52%	3.66%	0.40%	0.32%	0.26%	0.19%
Long-Term Debt to Total Capital	34.58%	34.07%	32.69%	33.55%	34.12%	35.10%	32.44%	34.98%	34.57%	35.58%	36.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.63%	65.29%	66.82%	65.95%	65.38%	64.38%	63.91%	64.62%	65.11%	64.16%	63.18%
Debt to EBITDA	2.51	2.05	2.14	2.32	2.94	2.75	2.86	2.72	2.13	1.70	1.35
Net Debt to EBITDA	0.90	0.42	0.10	0.11	0.44	0.69	0.11	0.07	0.19	0.24	1.35
Long-Term Debt to EBITDA	2.46	2.01	2.11	2.29	2.90	2.71	2.57	2.69	2.11	1.68	1.35
Debt to NOPAT	4.44	3.44	3.16	3.66	5.68	5.20	6.29	5.84	3.66	2.75	2.11
Net Debt to NOPAT	1.59	0.70	0.15	0.17	0.85	1.30	0.25	0.15	0.33	0.39	2.11
Long-Term Debt to NOPAT	4.34	3.37	3.12	3.61	5.60	5.12	5.65	5.77	3.62	2.73	2.10
Altman Z-Score	3.38	3.89	4.12	4.00	4.16	4.04	3.67	4.04	4.11	3.86	3.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.24	3.49	3.69	3.99	3.97	3.89	3.47	4.42	4.41	4.21	4.12
Quick Ratio	2.29	2.60	2.83	3.06	2.96	2.90	2.77	3.52	3.45	3.26	0.66
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-301	193	75	384	499	455	324	205	245	898	835
Operating Cash Flow to CapEx	421.39%	599.05%	1,211.22%	1,197.05%	1,044.29%	578.95%	492.76%	911.78%	642.68%	870.79%	533.54%
Free Cash Flow to Firm to Interest Expense	-10.33	6.34	2.34	12.03	15.44	17.48	11.55	7.39	9.00	31.95	34.64
Operating Cash Flow to Interest Expense	5.82	6.21	11.50	12.72	9.05	8.46	9.21	12.01	7.58	9.02	7.00
Operating Cash Flow Less CapEx to Interest Expense	4.44	5.17	10.55	11.66	8.19	7.00	7.34	10.70	6.40	7.98	5.68
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.47	0.44	0.44	0.44	0.45	0.44	0.43	0.43	0.48	0.54
Accounts Receivable Turnover	6.24	6.20	6.57	6.06	5.82	5.90	6.48	5.81	5.31	5.42	6.23
Inventory Turnover	2.86	2.68	2.78	2.70	2.97	2.97	3.16	3.10	2.95	3.07	3.32
Fixed Asset Turnover	7.45	7.59	7.64	7.80	7.75	7.77	8.07	8.21	8.07	8.52	9.30
Accounts Payable Turnover	9.49	8.55	9.51	9.50	10.17	10.10	10.51	9.83	8.68	9.09	9.02
Days Sales Outstanding (DSO)	58.54	58.84	55.52	60.20	62.72	61.83	56.29	62.80	68.70	67.40	58.56
Days Inventory Outstanding (DIO)	127.79	136.07	131.36	135.14	123.03	122.84	115.65	117.89	123.85	118.83	110.05
Days Payable Outstanding (DPO)	38.46	42.68	38.37	38.42	35.88	36.12	34.74	37.13	42.06	40.14	40.46
Cash Conversion Cycle (CCC)	147.86	152.24	148.50	156.91	149.86	148.54	137.20	143.57	150.48	146.09	128.15
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,525	5,290	5,247	5,068	5,230	5,297	5,136	5,254	5,560	5,496	5,378
Invested Capital Turnover	0.75	0.76	0.78	0.77	0.73	0.74	0.77	0.75	0.73	0.76	0.85
Increase / (Decrease) in Invested Capital	296	-6.70	111	-187	-330	-199	-242	-209	-32	-692	-718
Enterprise Value (EV)	14,666	16,992	18,889	17,445	18,685	18,144	17,110	20,000	20,156	18,794	18,565
Market Capitalization	13,760	16,476	18,772	17,328	18,300	17,501	16,999	19,928	19,897	18,391	15,723
Book Value per Share	$20.58	$21.03	$22.09	$21.21	$20.64	$19.50	$20.48	$21.05	$21.50	$20.72	$19.53
Tangible Book Value per Share	$1.43	$2.45	$3.63	$4.17	$3.41	$2.16	$3.46	$3.83	$3.25	$2.23	$1.44
Total Capital	7,146	7,310	7,677	7,507	7,410	7,229	7,850	8,019	8,142	7,937	7,718
Total Debt	2,528	2,537	2,547	2,556	2,565	2,575	2,834	2,837	2,841	2,845	2,841
Total Long-Term Debt	2,472	2,490	2,509	2,519	2,528	2,537	2,547	2,806	2,815	2,824	2,826
Net Debt	907	517	117	117	385	643	111	72	259	403	2,841
Capital Expenditures (CapEx)	40	32	30	34	28	38	53	37	32	29	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	654	565	490	593	692	701	542	625	700	644	2,939
Debt-free Net Working Capital (DFNWC)	2,275	2,538	2,824	3,032	2,872	2,633	3,264	3,390	3,283	3,086	2,939
Net Working Capital (NWC)	2,219	2,491	2,786	2,995	2,834	2,595	2,977	3,358	3,256	3,065	2,924
Net Nonoperating Expense (NNE)	13	-14	6.77	2.67	-0.88	8.89	-8.15	36	-5.63	18	-2.15
Net Nonoperating Obligations (NNO)	907	517	117	117	385	643	119	72	259	403	502
Total Depreciation and Amortization (D&A)	76	74	75	72	74	88	76	81	81	86	107
Debt-free, Cash-free Net Working Capital to Revenue	16.25%	14.00%	12.16%	14.87%	17.46%	17.65%	13.44%	15.47%	17.27%	14.43%	60.44%
Debt-free Net Working Capital to Revenue	56.51%	62.84%	70.06%	76.04%	72.50%	66.32%	80.99%	83.94%	80.92%	69.09%	60.44%
Net Working Capital to Revenue	55.11%	61.68%	69.13%	75.10%	71.56%	65.38%	73.87%	83.15%	80.27%	68.63%	60.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.08)	$0.87	$0.77	$0.83	$0.72	$1.03	$0.37	($0.16)	$0.88	$0.76	$0.49
Adjusted Weighted Average Basic Shares Outstanding	225.77M	230.28M	235.72M	234.60M	235.89M	238.63M	246.77M	246.91M	247.73M	247.32M	251.53M
Adjusted Diluted Earnings per Share	($0.08)	$0.87	$0.75	$0.82	$0.72	$1.03	$0.37	($0.16)	$0.87	$0.75	$0.48
Adjusted Weighted Average Diluted Shares Outstanding	225.77M	232.11M	237.55M	236.47M	237.56M	240.21M	248.83M	246.91M	249.79M	249.28M	253.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	222.85M	224.39M	226.94M	232.27M	233.38M	234.73M	240.00M	244.94M	246.12M	246.55M	245.83M
Normalized Net Operating Profit after Tax (NOPAT)	27	190	190	202	175	158	87	33	214	207	118
Normalized NOPAT Margin	2.64%	18.57%	19.28%	20.02%	17.16%	15.55%	9.18%	3.40%	20.87%	19.23%	12.36%
Pre Tax Income Margin	-2.84%	24.22%	22.43%	23.80%	20.78%	18.88%	15.40%	1.23%	27.21%	22.26%	15.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.49	8.32	7.06	7.66	6.81	7.28	4.90	0.26	10.11	8.78	6.57
NOPAT to Interest Expense	-0.17	6.12	5.81	6.18	5.23	9.82	2.93	-0.17	7.83	7.32	4.84
EBIT Less CapEx to Interest Expense	-1.87	7.29	6.11	6.59	5.94	5.82	3.04	-1.05	8.93	7.74	5.26
NOPAT Less CapEx to Interest Expense	-1.55	5.08	4.86	5.12	4.37	8.36	1.07	-1.49	6.65	6.28	3.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	157.28%	90.81%	105.78%	140.84%	214.71%	204.15%	104.12%	90.62%	43.17%	47.98%	41.64%

Frequently Asked Questions About Hologic's Financials

When does Hologic's financial year end?

According to the most recent income statement we have on file, Hologic's fiscal year ends in September. Their fiscal year 2024 ended on September 28, 2024.

How has Hologic's net income changed over the last 9 years?

Hologic's net income appears to be on an upward trend, with a most recent value of $789.50 million in 2024, rising from $131.60 million in 2015. The previous period was $456 million in 2023. See where experts think Hologic is headed by visiting Hologic's forecast page.

What is Hologic's operating income?

Hologic's total operating income in 2024 was $882.60 million, based on the following breakdown:

Total Gross Profit: $2.23 billion
Total Operating Expenses: $1.35 billion

How has Hologic revenue changed over the last 9 years?

Over the last 9 years, Hologic's total revenue changed from $2.71 billion in 2015 to $4.03 billion in 2024, a change of 49.0%.

How much debt does Hologic have?

Hologic's total liabilities were at $4.03 billion at the end of 2024, a 2.3% decrease from 2023, and a 27.6% decrease since 2015.

How much cash does Hologic have?

In the past 9 years, Hologic's cash and equivalents has ranged from $0.00 in 2021 to $2.72 billion in 2023, and is currently $2.16 billion as of their latest financial filing in 2024.

How has Hologic's book value per share changed over the last 9 years?

Over the last 9 years, Hologic's book value per share changed from 7.38 in 2015 to 22.09 in 2024, a change of 199.3%.

Related Companies

This page (NASDAQ:HOLX) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hologic (HOLX) Financials

Frequently Asked Questions About Hologic's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hologic (HOLX) Financials

Annual Income Statements for Hologic

Quarterly Income Statements for Hologic

Annual Cash Flow Statements for Hologic

Quarterly Cash Flow Statements for Hologic

Annual Balance Sheets for Hologic

Quarterly Balance Sheets for Hologic

Annual Metrics And Ratios for Hologic

Quarterly Metrics And Ratios for Hologic

Frequently Asked Questions About Hologic's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools